Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02107339
Other study ID # EH14-113
Secondary ID
Status Completed
Phase Phase 4
First received
Last updated
Start date March 2014
Est. completion date September 2017

Study information

Verified date September 2019
Source NorthShore University HealthSystem
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Patients undergoing major spinal surgery continue to experience moderate-to-severe pain during the first 2-3 days following the operative procedure. Pain complicates the recovery process, despite the routine practice of using potent opioid analgesics. The primary reason that pain is poorly controlled in patients undergoing major surgery is that most commonly-used opioids only produce analgesia for 2-4 hours. The intermittent use of these drugs results in periods of time when a patient will experience discomfort (at which time a nurse administers more drug or the button on a patient-controlled analgesic (PCA) system is pressed to deliver more medication). The use of a long-acting opioid may be advantageous in the perioperative setting. Methadone is an opioid that has a median duration of analgesia of 24-36 hours. Therefore, a single dose administered in the operating room may reduce the need for pain medication and improve pain control for the first few postoperative days. The aim of this randomized clinical trial is to examine the effect of methadone (compared to hydromorphone) on postoperative pain management in patients undergoing major spine surgery


Description:

Patients: 100 patients (ages 18-80) will be enrolled in this clinical trial. All patients presenting for elective posterior lumbar or thoracic spinal fusion surgery will be eligible for enrollment. Patients will be randomized to receive either methadone or hydromorphone on the basis of a computer generated random number table. Patients in each group will receive standard clinical intraoperative doses of either methadone (0.2 mg/kg) or hydromorphone (2 mg). An analysis of patients undergoing posterior lumbar fusion surgery at Evanston Hospital revealed that patients received, on average, approximately 2 mg of hydromorphone intraoperatively. The most commonly used doses of methadone administered in clinical studies have been either 0.2 mg/kg or a dose of 20 mg. Furthermore, these doses also represent dosages which appear to be approximately equipotent. Study medications will be prepared by the pharmacy, and all clinicians will be blinded to group assignment. Two syringes will be prepared for each patient, one which contains the study drug (either methadone 0.2 mg/kg or hydromorphone 2 mg), and the other containing the placebo (saline). If the patient is randomized to the methadone group, a 3 cc syringe containing 0.2 mg/kg of methadone and saline (total volume 3 cc) will be prepared, as well as a 10 cc syringe containing 10 cc of saline (placebo). If the patient is randomized to the hydromorphone group, a 3 cc syringe containing 3 cc of saline (placebo) will be prepared, as well as a 10 cc syringe containing 2 mg of hydromorphone with 9 cc of saline (total volume 10 cc). At induction of anesthesia, the 3 cc syringe containing either 0.2 mg/kg of methadone or placebo will be given over 5 seconds. At the conclusion of surgery, the 10 cc syringe of either hydromorphone or placebo will be titrated slowly per clinician's preference. The administration of all other anesthetic agents will be standardized and reflect the usual practices of anesthesiologists at Evanston Hospital (spine protocol).

Anesthesia will be standardized and include propofol for induction, a propofol and remifentanil infusion for maintenance (plus sevoflurane), and IV acetaminophen 1000 mg during the last 60 minutes of the case.

On arrival to the postanesthesia care unit (PACU), patients will be assessed for pain by PACU nurses per standard protocols. Patients will be evaluated for pain on PACU arrival and then every 15 minutes. Patients will be administered hydromorphone 0.25-0.5 mg for pain, and doses will be repeated until the patient is comfortable (pain < 3 on a scale of 0-10; 0=no pain and 10=worst pain imaginable). The patient will then be connected to a PCA device to deliver pain medication during the remainder of the postoperative period.

All postoperative management will be per standard surgical protocols

Sample Size: The primary end-point of the investigation is amount of hydromorphone used. In a clinical trial by Urban et al. of patients undergoing complex spine surgery using a standard anesthetic, average hydromorphone consumption in the first 24 hours was 27 mg (18). The investigators expect to see at least a 33% reduction in hydromorphone consumption in the methadone group. Group sample sizes of 39 and 39 achieve 91% power to detect a difference of 9.0 between the null hypothesis that both group means are 27.0 and the alternative hypothesis that the mean of group 2 is 18.0 with estimated group standard deviations of 10.0 and 10.0 and with a significance level (alpha) of 0.01000 using a two-sided two-sample t-test. The investigators plan to enroll a total of 100 patients to ensure complete collection of data.


Recruitment information / eligibility

Status Completed
Enrollment 120
Est. completion date September 2017
Est. primary completion date July 2016
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria:

- All patients presenting for elective posterior lumbar or thoracic spinal fusion surgery will be eligible for enrollment.

Exclusion Criteria:

1. Preoperative renal failure (defined as a serum creatinine > 2.0 mg/dL.)

2. American Society of Anesthesiologists Physical Status IV or V

3. Pulmonary disease necessitating home oxygen therapy

4. Allergy to methadone or hydromorphone

5. Preoperative recent history of opioid or alcohol abuse

6. Inability to use a PCA device or speak the English language

Study Design


Intervention

Drug:
Methadone
Methadone 0.2 mg/kg administered at induction of anesthesia
Hydromorphone
Hydromorphone 2 mg administered at the conclusion of anesthesia

Locations

Country Name City State
United States NorthShore University HealthSystem Evanston Illinois

Sponsors (1)

Lead Sponsor Collaborator
NorthShore University HealthSystem

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Hydromorphone Use at 24 Hours Use of hydromorphone at 24 hours
Secondary Hydromorphone Use Second 24 Hours 24-48 hours after surgery
Secondary Hydromorphone Use Third 24 Hours 48-72 hours after surgery
Secondary Pain Scores Postanesthesia Care Unit (PACU) Arrival 11-point verbal rating scale (0=no pain, 10=worst pain imaginable) First 5 minutes after PACU arrival
Secondary Pain Scores 1 Hour After PACU Arrival 11-point verbal rating scale (0=no pain, 10=worst pain imaginable) Pain scores at 60 minutes after PACU admission
Secondary Pain Scores 2 Hours After PACU Arrival 11-point verbal rating scale (0=no pain, 10=worst pain imaginable) Pain scores at 120 minutes after PACU admission
Secondary Pain Scores on Postoperative Day One 11-point verbal rating scale (0=no pain, 10=worst pain imaginable) Pain scores one day after PACU admission
Secondary Pain Scores on Postoperative Day 2 11-point verbal rating scale (0=no pain, 10=worst pain imaginable) Pain scores 48 hours after PACU admission
Secondary Pain Scores Postoperative Day 3 11-point verbal rating scale (0=no pain, 10=worst pain imaginable) Pain scores 72 hours after PACU admission
Secondary Patient Satisfaction Scores Patient satisfaction with overall pain management will be determined using a 101-point verbal rating scale (0=highly dissatisfied (worst), 100=highly satisfied (best)) Postopertive day 1
Secondary Patient Satisfaction Scores Patient satisfaction with overall pain management will be determined using a 101-point verbal rating scale (0=highly dissatisfied (worst), 100=highly satisfied (best)) postoperative day 2
Secondary Patient Satisfaction Scores Patient satisfaction with overall pain management will be determined using a 101-point verbal rating scale (0=highly dissatisfied (worst), 100=highly satisfied (best)) Postoperative day 3
Secondary Chronic Persistent Surgical Pain-Weekly Frequency of Pain 0=< once per week; 1=once per week; 2=twice per week; 3=daily; 4=constant One month after surgery
Secondary Chronic Persistent Surgical Pain-weekly Frequency of Pain 0=< once per week; 1=once per week; 2=twice per week; 3=daily; 4=constant 3 months after surgery
Secondary Chronic Persistent Surgical Pain-Weekly Frequency of Pain 0=< once per week; 1=once per week; 2=twice per week; 3=daily; 4=constant 6 months after surgery
Secondary Chronic Persistent Surgical Pain-Weekly Frequency of Pain 0=< once per week; 1=once per week; 2=twice per week; 3=daily; 4=constant 12 months after surgery
See also
  Status Clinical Trial Phase
Not yet recruiting NCT04079543 - NPO and Patient Satisfaction in the Cath Lab N/A
Enrolling by invitation NCT05053958 - Using Superimposition of Intra-Oral Scan and CBCT in Single Implant Restorations in Aesthetic Zone. N/A
Completed NCT04204785 - Noise in the OR at Induction: Patient and Anesthesiologists Perceptions N/A
Completed NCT04774562 - The Effect of Video-Assisted Discharge Education After Total Hip Replacement Surgery N/A
Terminated NCT04604340 - Radial Versus Femoral Arterial Access for Cerebral Angiography in Adolescents N/A
Recruiting NCT04539210 - Screw-retained Maxillary Complete Denture With Electric Welded Metal Framework Versus Cast One, Patient Satisfaction Assessment. N/A
Completed NCT02924974 - Spinal Morphine in Robotic Assisted Radical Prostatectomy Phase 4
Completed NCT01052415 - POL and Access Intervention to Reduce HIV Stigma Among Service Providers in China N/A
Recruiting NCT06044103 - Patient-controlled Sedation During Repair of Obstetric Perineal Lacerations Phase 4
Not yet recruiting NCT05670080 - Does MI Have a Therapeutic Role in Arthroscopic Rotator Cuff Repair? N/A
Completed NCT06114524 - Effect of Binaural Beats on Level of Anxiety and Toleration in Patients Undergoing Upper Gastrointestinal Endoscopy Without Sedation N/A
Completed NCT06141122 - The Colonoscopy Booklet:Effect of a Recipe Resource on Quality of Colonoscopy Bowel Preparation and Patient Experience N/A
Not yet recruiting NCT04534868 - Patient Acceptance And Satisfaction of Teledermoscopy In General Practice In a Belgian Rural Area N/A
Completed NCT04823390 - Anesthetist Controlled Versus Patient-controlled Sedation: Risks and Benefits Phase 1
Recruiting NCT05884684 - What is the Potential Impact of Reviewing Post-procedure Images With Patients Following Interventional Spine Procedures. N/A
Recruiting NCT05613439 - The Fast-track Centre for Hip and Knee Replacement Database
Recruiting NCT06451510 - Knee Osteoarthritis in the Region of Norrbotten
Completed NCT04420000 - Effects of Mindfulness Therapy in Patients With Acromegaly and Cushing N/A
Withdrawn NCT04625842 - Focus Group Interview Study on Patient Experiences and Satisfaction N/A
Recruiting NCT04842240 - Comparison of Patient Reported Outcome Measures Using the BREAST-Q Questionnaire in Patients Undergoing Pre Versus Sub-pectoral Implant Based Immediate Breast Reconstruction.